amprenavir / vitamin E
- RxCUI
- 1009018
- RxNorm name
- amprenavir / vitamin E
- Term type
- MIN
- Status
- Active
- Updated
- 2026-07-15 00:08:57
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- YES
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| vitamin E | 11256 |
| amprenavir | 228656 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| RXNAV_STR | amprenavir / vitamin E | NAMES |
| RxNorm Name | amprenavir / vitamin E | NAMES |
| TTY | MIN | ATTRIBUTES |
| RxCUI | 1009018 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A11HA | Other plain vitamin preparations | ATC1-4 | vitamin E | |
| ATC | J05AE | Protease inhibitors | ATC1-4 | amprenavir | |
| FDASPL | N0000175889 | Protease Inhibitor | EPC | has_epc | amprenavir |
| FDASPL | N0000185506 | Cytochrome P450 3A4 Inducers | MOA | has_moa | amprenavir |
| FDASPL | N0000182141 | Cytochrome P450 3A4 Inhibitors | MOA | has_moa | amprenavir |
| FDASPL | N0000000246 | HIV Protease Inhibitors | MOA | has_moa | amprenavir |
| FDASPL | N0000191264 | P-Glycoprotein Inducers | MOA | has_moa | amprenavir |
| MEDRT | D016589 | Astemizole | CHEM | ci_chemclass | amprenavir |
| MEDRT | D015764 | Bepridil | CHEM | ci_chemclass | amprenavir |
| MEDRT | D002219 | Carbamates | CHEM | has_ingredient | amprenavir |
| MEDRT | D020117 | Cisapride | CHEM | ci_chemclass | amprenavir |
| MEDRT | D020008 | Delavirdine | CHEM | ci_chemclass | amprenavir |
| MEDRT | D004087 | Dihydroergotamine | CHEM | ci_chemclass | amprenavir |
| MEDRT | D004221 | Disulfiram | CHEM | ci_chemclass | amprenavir |
| MEDRT | D004874 | Ergonovine | CHEM | ci_chemclass | amprenavir |
| MEDRT | D004878 | Ergotamine | CHEM | ci_chemclass | amprenavir |
| MEDRT | D005424 | Flecainide | CHEM | ci_chemclass | amprenavir |
| MEDRT | D005663 | Furans | CHEM | has_ingredient | amprenavir |
| MEDRT | D008148 | Lovastatin | CHEM | ci_chemclass | amprenavir |
| MEDRT | D000069056 | Lurasidone Hydrochloride | CHEM | ci_chemclass | amprenavir |
| MEDRT | D008755 | Methylergonovine | CHEM | ci_chemclass | amprenavir |
| MEDRT | D008795 | Metronidazole | CHEM | ci_chemclass | amprenavir |
| MEDRT | D008874 | Midazolam | CHEM | ci_chemclass | amprenavir |
| MEDRT | D010868 | Pimozide | CHEM | ci_chemclass | amprenavir |
| MEDRT | D011405 | Propafenone | CHEM | ci_chemclass | amprenavir |
| MEDRT | D011799 | Quinazolines | CHEM | ci_chemclass | amprenavir |
| MEDRT | D012293 | Rifampin | CHEM | ci_chemclass | amprenavir |
| MEDRT | D019438 | Ritonavir | CHEM | ci_chemclass | amprenavir |
| MEDRT | D000068677 | Sildenafil Citrate | CHEM | ci_chemclass | amprenavir |
| MEDRT | D019821 | Simvastatin | CHEM | ci_chemclass | amprenavir |
| MEDRT | D013449 | Sulfonamides | CHEM | has_ingredient | amprenavir |
| MEDRT | D014229 | Triazolam | CHEM | ci_chemclass | amprenavir |
| MEDRT | D014810 | Vitamin E | CHEM | has_ingredient | vitamin E |
| MEDRT | D000163 | Acquired Immunodeficiency Syndrome | DISEASE | may_treat | amprenavir |
| MEDRT | D000544 | Alzheimer Disease | DISEASE | may_prevent | vitamin E |
| MEDRT | D000544 | Alzheimer Disease | DISEASE | may_treat | vitamin E |
| MEDRT | D000743 | Anemia, Hemolytic | DISEASE | may_prevent | vitamin E |
| MEDRT | D000743 | Anemia, Hemolytic | DISEASE | may_treat | vitamin E |
| MEDRT | D001997 | Bronchopulmonary Dysplasia | DISEASE | may_prevent | vitamin E |
| MEDRT | D002648 | Child | DISEASE | ci_with | amprenavir |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | amprenavir |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | vitamin E |
| MEDRT | D004409 | Dyskinesia, Drug-Induced | DISEASE | may_treat | vitamin E |
| MEDRT | D004409 | Dyskinesia, Drug-Induced | DISEASE | may_prevent | vitamin E |
| MEDRT | D007223 | Infant | DISEASE | ci_with | amprenavir |
| MEDRT | D017093 | Liver Failure | DISEASE | ci_with | amprenavir |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | amprenavir |
| MEDRT | D051437 | Renal Insufficiency | DISEASE | ci_with | amprenavir |
| MEDRT | D014811 | Vitamin E Deficiency | DISEASE | may_prevent | vitamin E |
| MEDRT | D014811 | Vitamin E Deficiency | DISEASE | may_treat | vitamin E |
| MEDRT | N0000009919 | Adrenergic alpha1-Antagonists | MOA | ci_moa | amprenavir |
| MEDRT | N0000190118 | Cytochrome P450 3A Inducers | MOA | ci_moa | amprenavir |
| MEDRT | N0000000170 | Free Radical Scavenging Activity | MOA | has_moa | vitamin E |
| MEDRT | N0000000246 | HIV Protease Inhibitors | MOA | has_moa | amprenavir |
| MEDRT | N0000000121 | Hydroxymethylglutaryl-CoA Reductase Inhibitors | MOA | ci_moa | amprenavir |
| MEDRT | N0000009948 | Non-Nucleoside Reverse Transcriptase Inhibitors | MOA | ci_moa | amprenavir |
| MEDRT | N0000020026 | Phosphodiesterase 5 Inhibitors | MOA | ci_moa | amprenavir |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | amprenavir |
| MEDRT | N0000009934 | Decreased Vitamin Uptake and Modification | PE | has_pe | vitamin E |
| MEDRT | N0000009357 | Increased Immunologically Active Molecule Activity | PE | has_pe | amprenavir |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | TTY | MIN |
| CODES | RxCUI | 1009018 |
| NAMES | RXNAV_STR | amprenavir / vitamin E |
| NAMES | RxNorm Name | amprenavir / vitamin E |